Semaglutide puas yog rau koj?

Raws li lub ntiaj teb kev rog rog nce ntxiv, qhov hnyav - kev kho mob poob qis raws li incretin (GLP-1) txoj hauv kev tau txais kev nyiam ntawm cov neeg nrhiav kev kho mob hnyav dua. Txawm li cas los xij, tseem muaj ntau qhov kev xav tsis zoo rau pej xeem txog lawv txoj kev nyab xeeb, tsim nyog, thiab muaj txiaj ntsig mus ntev.

Kab lus no tau tshuaj xyuas qhov hnyav -cov tshuaj poob qis uas sawv cev los ntawm semaglutide thiab liraglutide los ntawm kev xav ntawm cov neeg muaj peev xwm sib tw, cov neeg uas yuav tsum tsis txhob siv, pov thawj kev tshawb fawb, cov kws tshaj lij pom zoo, thiab kev soj ntsuam kev pom zoo, pab cov nyeem txiav txim siab seb cov kev kho mob no puas haum rau lawv cov kev xav tau kev kho mob. Nws yog ib qho tseem ceeb uas yuav tsum tau hais txog tias kev sib koom ua ke ntawm kev kho tshuaj nrog kev cuam tshuam ntawm kev ua neej nyob ib leeg tseem yog lub hauv paus ntawm kev ua tiav ntev - kev txhim kho kev noj qab haus huv.

Cov pov thawj tam sim no -raws li cov lus qhia kho mob txhawb kev siv qhov hnyav- kev txhaj tshuaj feem ntau rau cov tib neeg hauv qab no:

1. Lub cev qhov ntsuas qhov ntsuas (BMI) Ntau dua lossis sib npaug li 30 kg / m²
2. Los yog BMI Ntau dua lossis sib npaug li 27 kg / m² nrog tsawg kawg ib qho rog rog -txog comorbidity, xws li:

• Mob ntshav qab zib hom 2
• Ntshav siab
• Dyslipidemia
• Obstructive pw tsaug zog apnea

Hauv qhov tiag -kev txiav txim siab hauv ntiaj teb no-, cov kws kho mob kuj xav txog:

• Hnub nyoog thiab keeb kwm kho mob
• Qhov hnyav dhau los- poob sim thiab qhov tshwm sim
• Muaj peev xwm ua raws li lub sijhawm ntev - kev noj haus, kev tawm dag zog, thiab kev cuam tshuam tus cwj pwm

Rau cov tib neeg uas tawm tsam kom ua tiav qhov hnyav txo qis los ntawm kev hloov pauv kev ua neej nyob ib leeg, GLP-1 receptor agonists tuaj yeem ua haujlwm zoo rau kev kho mob.

Cov kev tshawb fawb pom tau hais tias piv nrog kev noj zaub mov thiab kev tawm dag zog ib leeg, sib txuas nrog semaglutide lossis liraglutide nrog kev cuam tshuam hauv kev ua neej ua rau poob phaus ntau dua thiab txhim kho cov ntshav qabzib, ntshav siab, thiab lipid profile, yog li txo qis kev pheej hmoo ntawm cardiometabolic.

Nws yog ib qho tseem ceeb kom nkag siab tias cov tshuaj no tsis yog "ceev- kho cov tshuaj slimming" lossis cov kev daws teeb meem txuj ci tseem ceeb. Cov txiaj ntsig muaj txiaj ntsig zoo thiab muaj txiaj ntsig yog nyob ntawm kev siv kho mob kom zoo nrog rau kev tswj hwm kev ua neej ntev ntev.

Txawm hais tias cov tshuaj no tau pom qhov ua tau zoo, qhov hnyav - kev txhaj tshuaj tsis haum rau txhua tus.

Tsis muaj contraindications

• Tus kheej los yog tsev neeg keeb kwm ntawmmedullary thyroid carcinoma (MTC)los yogNtau yam endocrine neoplasia syndrome hom 2 (MEN2)
• Kev tsis haum tshuaj hnyav rau ib feem ntawm cov tshuaj
• Cov poj niam cev xeeb tub los yog pub niam mis

Kev ceeb toom mob qog noj ntshav thyroid feem ntau yog raws li kev tshawb fawb tsiaj. Txawm hais tias kev sib raug zoo ntawm tib neeg tsis tau lees paub, cov kev pheej hmoo no tseem muaj npe raws li contraindications rau kev nyab xeeb.

Siv nrog ceev faj lossis kaw kaw

• Keeb kwm ntawm pancreatitis
• Tus kab mob gallbladder nquag los yog rov tshwm sim dua
• Mob plab hnyuv loj
• Cov tib neeg ua rau lub cev qhuav dej lossis lub raum tsis zoo vim ntuav lossis raws plab
• Cov neeg mob uas tswj tsis tau kev noj zaub mov tsis zoo lossis kev puas siab puas ntsws hnyav

Ua ntej muab cov tshuaj no, cov kws kho mob feem ntau ua qhov kev ntsuam xyuas, suav nrog lub siab thiab lub raum kev ua haujlwm, lub gallbladder noj qab haus huv, thiab kev puas siab puas ntsws, kom txo qis kev pheej hmoo ntawm cov xwm txheej phem.

Ntau qhov kev sim tshuaj ntsuam xyuas tau lees paub qhov ua tau zoo ntawm GLP-1 receptor agonists rau kev tswj qhov hnyav.

KAUJ RUAM 1 kev sim pom tau hais tias semaglutide 2.4 mg ua ke nrog kev cuam tshuam kev ua neej ua rau qhov hnyav nruab nrab ntawm kwv yees li 14.9% tom qab 68 lub lis piam, piv nrog kwv yees li 2.4% hauv pawg placebo.

Liraglutide 3.0 mg tau ua tiav kwv yees li 8% poob qis dua 56 lub lis piam, ua tau zoo dua cov pab pawg placebo uas tau ntsib kwv yees li 2-3%.

Main Mechanisms of Action

• Ua haujlwm ntawm lub hauv nruab nrab paj hlwb kom txo qis qab los noj mov
• Txo qis zog tag nrho
• Kev ncua lub plab zom mov thaum lub sijhawm kho thaum ntxov
• Txhim kho cov tshuaj insulin rhiab heev thiab tswj cov ntshav qabzib

Tshaj li qhov txo qhov hnyav, cov tshuaj no tuaj yeem txo qis HbA1c ntau ntau thiab tau pom cov txiaj ntsig zoo ntawm cov hlab plawv hauv qee qhov kev tshawb fawb.

Txawm li cas los xij, qhov hnyav rov qab tom qab txiav tawm yog feem ntau. Yog tias tsis muaj sijhawm ntev - cov tswv yim tu ncua uas suav nrog kev noj zaub mov, kev tawm dag zog, thiab kev tswj tus cwj pwm, qee tus neeg mob yuav maj mam rov qab mus rau lawv qhov hnyav ua ntej - kho.

Ntau cov lus qhia thoob ntiaj teb thiab cov kws tshaj lij cov lus pom zoo tsis tu ncua hais tias kev kho tshuaj yuav tsum yog ib feem ntawm qhov hnyav hnyav - kev tswj hwm lub tswv yim es tsis yog kev daws teeb meem ib leeg.

Hauv kev xyaum kho mob, endocrinologist feem ntau pom zoo:

• Tshuaj + kev noj zaub mov noj
• Tshuaj + kev ua si lub cev tsis tu ncua
• Tshuaj + kev coj tus cwj pwm thiab kev puas siab puas ntsws txhawb nqa

Kaw ua raws- nce thaum lub sij hawm kho thaum ntxov yog qhov tseem ceeb los saib xyuas kev mob siab rau, cov kev mob tshwm sim, thiab qhov hnyav - poob qis, nrog kev noj tshuaj lossis kev kho mob thaum tsim nyog.

Cov kws kho mob noj zaub mov thiab cov kws kho mob tseem ceeb kuj tseem ceeb tias kev txhim kho kev noj zaub mov kom ruaj khov thiab kev ua neej nyob yog qhov tseem ceeb rau kev ua tiav ntev -.

Kev tiv thaiv kab mob -Kev rog rog kev kho mob raws li GLP-1 receptor agonists, xws li semaglutide thiab liraglutide, muab kev pab kho mob tseem ceeb thiab muaj txiaj ntsig rau cov tib neeg uas tawm tsam kev rog rog thiab cuam tshuam txog cov teeb meem metabolic.

Cov pov thawj tam sim no qhia tau hais tias thaum cov tshuaj no tau ua ke nrog kev tswj hwm kev noj zaub mov, kev ua si lub cev, thiab kev coj cwj pwm, lawv tuaj yeem tsim kho qhov hnyav poob thiab txhim kho metabolic. Txawm li cas los xij, lawv tsis tsim nyog rau txhua tus. Qee yam mob hauv qab no, cov neeg tshwj xeeb, thiab keeb kwm ntawm tus kheej lossis tsev neeg tuaj yeem sawv cev rau contraindications lossis yuav tsum tau siv ceev faj raws li kev saib xyuas thiab saib xyuas kev kho mob.

Tsis tas li ntawd, kev mob plab hnyuv xws li xeev siab, ntuav, thiab raws plab qhia txog qhov tseem ceeb ntawm kev saib xyuas kev kho mob zoo. Cov kws tshaj lij feem ntau pom zoo tias cov tshuaj no ua haujlwm zoo tshaj plaws raws li ib feem ntawm qhov hnyav tag nrho- kev tswj hwm lub tswv yim es tsis yog hloov pauv kev ua neej. Yog tsis muaj - cov phiaj xwm tu ncua ntev, cov txiaj ntsig kev kho mob yuav txo qis, thiab qhov hnyav rov qab los tom qab txiav tawm tseem yog ib qho kev txhawj xeeb tseem ceeb.

Kev tswj tus kheej ntawm kev noj zaub mov, kev coj cwj pwm, thiab kev puas siab puas ntsws zoo - tseem yog tus yuam sij rau kev vam meej mus ntev.

Raws li kev tshawb fawb txuas ntxiv mus, cov pov thawj hais txog cov tswv yim siv tshuaj zoo, kev nyab xeeb ntev -, thiab kev sib xyaw ua ke yuav ua kom zoo dua qub. Rau cov tib neeg xav txog cov kev kho mob no, kev txiav txim siab raws li cov pov thawj scientific, cov kws tshaj lij kev taw qhia, thiab kev noj qab haus huv ntawm tus kheej - nrog rau kev sab laj nrog cov kws kho mob uas tsim nyog - yog qhov tseem ceeb hauv kev txiav txim siab seb txoj hauv kev no puas yog txoj hauv kev rau lawv qhov hnyav - tswj kev taug kev.

Los ntawm kev sib koom ua ke kev kho mob nrog kev hloov pauv kev ua neej nyob ruaj khov, ntau tus neeg tuaj yeem ua tiav kev noj qab haus huv thiab ntev dua - qhov hnyav dua - kev tswj cov txiaj ntsig.

Cov ntaub ntawv

[1] Zheng, Z., Zong, Y., Ma, Y., Tian, ​​Y., Pang, Y., Zhang, C., & Gao, J. (2024). Glucagon-zoo li peptide-1 receptor: cov txheej txheem thiab kev nce qib hauv kev kho. Kev Hloov Pauv Hloov thiab Lub Hom Phiaj Kho, 9(1), 234.https://doi.org/10.1038/s41392-024-01931-z

[2] Popoviciu, MS, Păduraru, L., Yahya, G., Metwally, K., & Cavalu, S. (2023). Lub luag haujlwm tseem ceeb ntawm GLP-1 agonists hauv kev rog rog: kev tshuaj xyuas dav dav ntawm kev sim tswj kev sim. International Journal of Molecular Sciences, 24(13), 10449. https://doi.org/10.3390/ijms241310449.

[3] Jensterle, M., Rizzo, M., Haluzík, M., & Janež, A. (2022). Kev ua tau zoo ntawm GLP-1 RA tau pom zoo rau kev tswj qhov hnyav hauv cov neeg mob uas muaj lossis tsis muaj ntshav qab zib: cov lus piav qhia. Advances in therapy, 39(6), 2452-2467.https://doi.org/10.1007/s12325-022-02153-x

[4] Horn, DB, Almandoz, JP, & Saib, M. (2022). Dab tsi yog qhov chaw kho mob qhov hnyav poob rau koj cov neeg mob thiab nws ua tiav li cas? Ib tug piav qhia. Postgraduate Medicine, 134(4), 359-375. https://doi.org/10.1080/00325481.2022.2051366

[5] Qi, QYD, Cox, A., McNeil, S., & Sumithran, P. (2024). Cov tshuaj noj rog rog: cov lus piav qhia ntawm cov neeg sawv cev tam sim no thiab tawm tshiab. Osteoarthritis thiab pob txha mos qhib, 100472. https://doi.org/10.1016/j.ocarto.2024.100472

[6] Chao, AM, Tronieri, JS, Amaro, A., & Wadden, TA (2022). Kev soj ntsuam pom ntawm semaglutide rau kev tswj qhov hnyav hnyav hauv cov neeg laus: kev xaiv tus neeg mob thiab kev txiav txim siab tshwj xeeb. Drug design, development and therapy, 4449-4461.https://doi.org/10.2147/DDDT.S365416

[7]Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., ... & Wilding, JP (2015). Ib qho randomized, tswj kev sim ntawm 3.0 mg ntawm liraglutide hauv kev tswj qhov hnyav. New England Journal of Medicine, 373(1), 11-22. https://doi.org/10.1056/NEJMoa1411892

[8] Drucker, DJ (2018). Mechanisms ntawm kev txiav txim thiab kev kho mob ntawm glucagon-zoo li peptide-1. Cell metabolism, 27(4), 740-756. https://doi.org/10.1016/j.cmet.2018.03.001

[9] Garvey, WT, Mechanick, JI, & Einhorn, D. (2014). Lub koom haum American Association of Clinical Endocrinologists thiab American College of Endocrinology: 2014 advanced framework for a new diagnosis of obesity as a chronic disease. Endocrine xyaum: official journal ntawm American College of Endocrinology thiab American Association of Clinical Endocrinologists, 20(9), 977. https://doi.org/10.4158/EP14280.PS

Yog koj xav yuavSemaglutide Peptide Txhajthiab xav kawm ntxiv lwm yam khoom, thov hu rau Xi'an Ruichi. Peb tos ntsoov yuav hnov ​​​​los ntawm koj.

Email:Jenny@ruichibio.com

Siv:https://www.ruichibio.com/lyophilized-peptide/semaglutide-peptide-injection.html